Researchers have substantially improved its progress of an new therapy for amyloid heart disease, utilizing Attruby. Preliminary trial data suggests potential outcomes for patients affected with the serious disease. This effort highlights researchers’ dedication to treating significant healthcare demands in a cardiology field. Attruby: BridgeBio